Semaglutide Before and After: Weight Loss Results and What to Expect

Dr. Crystal Broussard, MD

Board Certified in Family Medicine  ·  Specialized Training in Obesity Medicine

Updated March 30, 2026

Semaglutide Weight Loss Before and After: What the Clinical Evidence Shows

When patients search “semaglutide weight loss before and after,” they’re really asking three questions: Will this work for me, how much weight can I expect to lose, and how long will it take?

Semaglutide is FDA-approved for chronic weight management in adults with obesity or overweight plus weight-related comorbidities. The landmark evidence comes from the STEP 1 trial, a 68-week study showing 14.9% average weight loss vs. 2.4% with placebo New England Journal of Medicine 2021.

As Dr. Crystal Broussard, MD (Board Certified in Family Medicine with Specialized Training in Obesity Medicine), I use semaglutide as part of comprehensive, physician-supervised weight management programs at Harmony Aesthetics Spa. This article will cover what the clinical data shows about weight loss timelines, percentage benchmarks, individual variation, and how physician supervision with body composition monitoring optimizes outcomes.

Individual results vary. What follows is based on published clinical trials in controlled settings. Real-world results depend on adherence, lifestyle factors, and the quality of medical oversight.

Important Safety Information

Semaglutide is a prescription medication with specific indications, contraindications, and potential side effects. It is FDA-approved for chronic weight management in adults with BMI ≥30 kg/m² or BMI ≥27 kg/m² with at least one weight-related comorbidity FDA 2024.

Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. Most are mild to moderate and decrease over time. Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Patients with a history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy should discuss risks and benefits with their physician. This medication requires medical supervision, proper dosing, and integration with lifestyle intervention.

The FDA has issued alerts regarding compounded semaglutide dosing errors FDA 2024. I emphasize the importance of using FDA-approved formulations under physician supervision.

How Semaglutide Works for Weight Loss

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation and glucose metabolism Mayo Clinic 2025.

When administered weekly via subcutaneous injection, it activates GLP-1 receptors in the brain (particularly the hypothalamus) to reduce hunger and increase feelings of fullness after eating. It also slows gastric emptying, which prolongs satiety, and improves insulin sensitivity.

The result is a reduction in caloric intake that feels manageable rather than restrictive. Patients report feeling satisfied with smaller portions and experiencing fewer food cravings. This is not a stimulant or appetite suppressant in the traditional sense. It works by restoring normal satiety signaling that is often dysregulated in obesity American Board of Obesity Medicine 2021.

Semaglutide is most effective when combined with reduced-calorie diet and increased physical activity. It is a tool that supports lifestyle change, not a replacement for it.

Semaglutide Results: What the Clinical Trials Show

Average Weight Loss and Timelines

In the STEP 1 trial, adults with obesity or overweight plus comorbidities treated with semaglutide 2.4 mg weekly plus lifestyle intervention lost an average of 14.9% of total body weight over 68 weeks, compared to 2.4% with placebo New England Journal of Medicine 2021.

Weight loss begins early. Meaningful reductions are often visible within the first few weeks. Weight loss continues progressively over 6-12 months, with most patients reaching their maximum weight loss around 60-68 weeks.

The systematic review confirms these findings across multiple STEP trials and shows consistent results up to 2 years Diabetes, Obesity & Metabolism 2024. This is the clinical benchmark, but individual results vary. These are average outcomes from controlled trials. Real-world results depend on adherence, baseline health, and lifestyle factors.

Who Responds Best: Predictors of Weight Loss

While semaglutide produces significant weight loss across diverse patient populations, individual response varies. Research from the STEP cohorts shows that baseline BMI, adherence to the medication regimen, and presence of comorbidities can influence the magnitude of weight loss.

Sex differences in response are modest. Both men and women achieve substantial weight loss, though patterns may differ slightly. Adherence is one of the strongest predictors: patients who remain on treatment and follow lifestyle recommendations consistently see the best outcomes.

This underscores the importance of physician supervision and ongoing support. Weight loss is not just about the medication, but about the comprehensive program surrounding it. Some patients are “super-responders” who exceed average weight loss, while others may lose less than the trial average but still achieve clinically meaningful improvements in metabolic health.

Body Composition: Fat Loss vs. Muscle Loss

One of the most important questions in weight loss is not just how much weight is lost, but what type of tissue is lost. The STEP program body composition analyses show that semaglutide-induced weight loss is predominantly fat mass, with modest lean mass decline when muscle-preserving strategies are implemented.

This is a critical distinction: losing fat improves metabolic health, while losing muscle can reduce metabolic rate and functional capacity.

At Harmony Aesthetics Spa, I use weekly InBody scans to track body composition throughout treatment, monitoring fat mass, lean mass, and visceral fat separately. This allows for real-time adjustments to nutrition and exercise recommendations to maximize fat loss while preserving muscle.

Lean mass preservation was observed in the STEP trials when patients engaged in resistance training and adequate protein intake. In my practice, I emphasize these strategies from day one. This is an actionable insight, not just a trial finding. Resistance exercise and protein timing matter.

Beyond the Scale: Metabolic and Health Improvements

Weight loss is the primary outcome measured in semaglutide trials, but it’s not the only benefit. Patients in the STEP trials also experienced improvements in blood pressure, lipid profiles, glycemic control (even in non-diabetic patients), and markers of cardiovascular risk.

For patients with obesity-related comorbidities (such as prediabetes, hypertension, sleep apnea, or fatty liver disease), these metabolic improvements can be as important as the number on the scale Nature Medicine 2022.

This section also addresses the psychological and quality-of-life benefits: reduced food preoccupation, improved energy, better mobility, and increased confidence in social and physical activities.

Semaglutide is part of a long-term weight management strategy. Clinical trials show that weight regain is common after discontinuation, which is why ongoing medical supervision and lifestyle support are essential for sustained results Diabetes, Obesity & Metabolism 2022.

The 2-year data from STEP 5 shows durability of weight loss with continued treatment. But I also acknowledge that this is a chronic condition requiring ongoing management, much like hypertension or diabetes.

Semaglutide Weight Loss Programs in Spring, TX and Greater North Houston

Many adults in Spring, The Woodlands, Tomball, Kingwood, and surrounding North Houston communities are pursuing weight loss not just for appearance, but for health, longevity, and quality of life.

Whether that’s keeping up with active kids on the Spring Creek Greenway trails, managing chronic conditions like prediabetes or hypertension, or simply feeling more comfortable and confident in their own body, the motivation is deeply personal.

Physician-supervised semaglutide treatment at Harmony Aesthetics Spa offers a medical approach to weight management that goes beyond what’s available at commercial weight loss programs or through telehealth-only prescribing services.

My Specialized Training in Obesity Medicine and 20 years of clinical experience means I understand the metabolic, hormonal, and behavioral factors that influence weight. I tailor treatment to each patient’s unique health profile American Academy of Family Physicians 2021.

The weekly InBody monitoring is a key differentiator. It allows our care team to track not just weight, but body composition, ensuring that patients are losing fat and preserving muscle. This level of oversight and individualization is what separates physician-led medical weight loss from one-size-fits-all approaches.

Learn more about physician-supervised weight loss injections and how we integrate comprehensive metabolic health support into every treatment plan.

When Is It Time to Talk to Dr. Crystal About Semaglutide for Weight Loss?

You may be a candidate if:

Many patients feel frustrated or defeated after years of unsuccessful weight loss attempts, but that frustration is not a personal failing. It’s a sign that the underlying biology of weight regulation needs medical support. Semaglutide is not a quick fix or cosmetic treatment. It’s a medical intervention for a chronic condition.

If you’re ready to approach weight loss as a health priority with the support of a physician who specializes in Obesity Medicine, it’s time to schedule a consultation.

Patients who are motivated and able to engage with the full program (medication + lifestyle + monitoring) tend to see the best outcomes. Adherence matters. Lifestyle integration matters. Physician support matters.

What to Expect During Semaglutide Treatment at Harmony Aesthetics Spa

Initial consultation with me includes a comprehensive health assessment: medical history, current medications, weight history, metabolic labs (if needed), and discussion of goals and expectations.

If semaglutide is appropriate, treatment begins with a low dose (0.25 mg weekly) and is gradually titrated up over 16-20 weeks to the maintenance dose of 2.4 mg weekly. This dose escalation minimizes GI side effects and allows the body to adjust.

Injections are self-administered at home using a pre-filled pen. Patients receive training and support. Weekly InBody scans track body composition: total weight, fat mass, lean mass, visceral fat, and body water. This data guides adjustments to nutrition, exercise, and medication dosing.

Patients also receive ongoing lifestyle counseling and access to our care team for questions or concerns. This is not a “prescribe and disappear” model. It’s a physician-supervised program with regular monitoring and support.

Most patients begin to notice reduced appetite and easier portion control within the first 1-2 weeks. Visible weight loss typically becomes apparent by weeks 4-8, with continued progress over the following months.

GI side effects (nausea, diarrhea, constipation) are common early on but usually improve as the body adjusts and as our care team provides management strategies (e.g., eating smaller meals, avoiding high-fat foods, staying hydrated).

Choosing Your Weight Loss Program

One Patient’s Experience

As a physician, I know that seeing real results matters more than reading about possibilities. One of my patients in the Spring area recently shared her experience after starting semaglutide treatment with our weekly InBody monitoring program.

Individual results vary.

Her response reflects what I often observe when we match the right medical intervention to a patient’s specific metabolic profile and treatment history. Not every patient sees improvement this quickly, but stories like Amber’s remind me why physician-guided weight management programs matter.

Conclusion

Semaglutide is a proven, FDA-approved medication that research suggests produces clinically significant weight loss when used as part of a comprehensive, physician-supervised program. The clinical trial data is clear: patients lose an average of 12-15% of total body weight over 68 weeks. But individual results depend on adherence, lifestyle factors, and the quality of medical oversight.

At Harmony Aesthetics Spa, I combine semaglutide treatment with weekly body composition monitoring, individualized lifestyle guidance, and ongoing clinical support to help patients achieve sustainable fat loss while preserving muscle and metabolic health.

If you’re ready to approach weight loss as a medical priority with the support of a physician who specializes in Obesity Medicine, schedule a consultation to discuss whether semaglutide is right for you. We’re located at our Spring, TX location and serve patients throughout Spring and the greater North Houston area.

Frequently Asked Questions